Loss of Polycomb Repressive Complex 2 function causes asparaginase resistance in T-acute lymphoblastic leukemia through decreased WNT pathway activity
Lefeivre, T.; Tudose, C.; Grosu, T.-I.; Jones, L.; Leon, T.; Wynne, K.; Oliviero, G.; Smith, O.; Trinquand, A.; Mansour, M.; Ryan, C.; Bond, J.
Show abstract
Loss-of-function mutations and deletions in core components of the epigenetic Polycomb Repressive Complex 2 (PRC2) are associated with poor prognosis and treatment resistance in T-acute lymphoblastic leukemia (T-ALL). We leveraged clinical mutational and transcriptional data to identify a functional link between PRC2 alterations and changes in WNT signaling pathway activity in leukemia cells. Computational integration of transcriptomic, proteomic and phosphoproteomic data from an isogenic T-ALL cellular model revealed reduced activity of the WNT-dependent stabilization of proteins (WNT/STOP) pathway in cells lacking core PRC2 factor EZH2. We discovered that PRC2 loss significantly reduced sensitivity to key T-ALL treatment asparaginase, and that this was mechanistically linked to increased cellular ubiquitination levels that bolstered leukemia cell asparagine reserves. We further found that asparaginase resistance in PRC2-depleted leukemic blasts could be mitigated by pharmaceutical proteasome inhibition, thereby providing a novel and clinically tractable means to tackle induction treatment failure in high-risk T-ALL.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis 97%
- DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes 96%
- The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival 95%
Similar papers in this journal
- A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy 96%
- An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML 96%
- Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia 95%
Similar papers in this journal
- Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia 96%
- Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML 95%
- RNA-seq of Human T-Cells After Hematopoietic Stem Cell Transplantation Identifies Linc00402 as a Novel Regulator of T-Cell Alloimmunity 93%
Similar papers in this journal
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers 95%
- N-MYC regulates Cell Survival via eIF4G1 in inv(16) Acute Myeloid Leukemia 95%
- TCF3::HLF Orchestrates an Enhancer-Promoter Network with Activation of MEF2C to Promote Immature HSC gene Expression in Leukemia 95%
Similar papers in this journal
- A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML 96%
- Focal Deletions of a Promoter Tether Activate the IRX3 Oncogene in T Cell Acute Lymphoblastic Leukemia 95%
- BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.